Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy
NCT ID: NCT01553578
Last Updated: 2018-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
244 participants
INTERVENTIONAL
2012-02-29
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy
NCT06322615
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
NCT00321880
Healing Touch and Relaxation Therapies in Cervical Cancer Patients
NCT00084123
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
NCT06723041
Perceptions of Touch in People With Cancer
NCT00631735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To determine if the provision of healing touch or guided imagery during outpatient chemotherapy is associated with decreased pain, fatigue, nausea and anxiety when compared to standard outpatient treatment protocols.
OUTLINE: Patients are randomized to 1 of 3 treatment arms.
ARM A: Patients receive 30 minutes of healing touch therapy comprising magnetic clearing, pain drains, hands in motion/hands still and mind clearing.
ARM B: Patients listen to guided imagery audiotapes for 30 minutes
ARM C: Patients receive standard of care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A (healing touch therapy)
Patients receive 30 minutes of healing touch therapy consisting of magnetic clearing, pain drains, hands in motion/hands still and mind clearing.
questionnaire administration
Ancillary studies
therapeutic touch
Receive healing touch therapy
management of therapy complications
Receive healing touch therapy
Arm B (guided imagery)
Patients listen to guided imagery audiotapes for 30 minutes.
questionnaire administration
Ancillary studies
management of therapy complications
Receive guided imagery audiotapes
Arm C (standard care)
Patients receive standard of care.
questionnaire administration
Ancillary studies
standard follow-up care
Receive standard care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire administration
Ancillary studies
therapeutic touch
Receive healing touch therapy
management of therapy complications
Receive healing touch therapy
management of therapy complications
Receive guided imagery audiotapes
standard follow-up care
Receive standard care
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Hodges
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2012-00164
Identifier Type: REGISTRY
Identifier Source: secondary_id
CCCWFU 97511
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00018805
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.